bit.bio
- Biotech or pharma, therapeutic R&D
bit.bio designs and manufactures consistent, defined, and scalable human cells for research, drug discovery, and cell therapy. bit.bio has a partnership strategy that enables access to its proprietary opti-ox, deterministic cell programming technology, and cell identity coding platform. These technologies can reproducibly and consistently generate billions of defined human cells in days, not months.
Address
CambridgeCambridgeshire
United Kingdom
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}